Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy

Full text for this resource is not available from the Research Repository.

Tomek, Mary, Akiyama, Toru and Dass, Crispin R (2012) Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy. Journal of Pharmacy and Pharmacology, 64 (12). pp. 1695-1702. ISSN 0022-3573 (print) 2042-7158 (online)

Abstract

Bcl-2 is a protein that inhibits apoptosis, leading to cell survival. The Bcl-2 family has six different anti-apoptotic proteins, three pro-apoptotic proteins that are similar in structure, and other integrating proteins that function as promotors or inhibitors in the progression of apoptosis. In this discussion paper, we provide an overview of apoptosis, the role of Bcl-2 in normal cellular and molecular processes, and the role of Bcl-2 in tumour cell survival. It focuses primarily on anti-apoptotic Bcl-2, its activation in cancer, the manner in which it regulates the intrinsic and extrinsic mechanisms of apoptosis, and its broad molecular interactions with other critical proteins in the cell. Certain cancer treatments are reviewed and related directions for the future are presented.

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/23173
DOI https://doi.org/10.1111/j.2042-7158.2012.01526.x
Official URL http://onlinelibrary.wiley.com/doi/10.1111/j.2042-...
Subjects Historical > FOR Classification > 1112 Oncology and Carcinogenesis
Historical > FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
Current > Division/Research > College of Health and Biomedicine
Keywords ResPubID25800, apoptosis, Bcl-2, cancer, cell survival, FKBP-38, Nur-77, tumour cells
Citations in Scopus 52 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login